None listed
Conditions
Interventions
Patients in this study were randomised to receive either a brief self-help intervention based on cognitive behavioural therapy (CBT) principles or standard medical care across the same seven week period. The self-help intervention developed specifically for this study consists of a structured manual divided into seven weekly sessions. The first chapter provides a detailed biopsychosocial model of IBS that explains why patients continue to experience symptoms after their initial infection and justifies the approach used in the manual. The remaining chapters provide behavioural guidelines for managing diarrhoea and constipation, advice on behavioural change for diet and exercise, cognitive strategies to challenge unhelpful thoughts or beliefs about symptoms, identifying and managing perfectionism, as well as stress and sleep management. Patients received the manual together with an initial face-to-face session with a CBT therapist explaining the programme and the model of IBS and two one-hour phone call follow-ups at 3 and 5 weeks into the programme with the same therapist.
Sponsors
Study design
Eligibility
Inclusion criteria
(a) a diagnosis of IBS based on Rome I modified and/or Rome II criteria. (b) a diagnosis of IBS subsequent to an episode of gastroenteritis (c) between the ages of 18-70 (d) primary care attendees in the greater Auckland area.
Exclusion criteria
(a) Patients who have another medical condition that may affect their symptoms or preclude a diagnosis of IBS such as previous bowel surgery or a malignancy, ceoliac disease, inflammatory bowel disease, or obstructive bowel pathology (b) Patients who have any serious psychological disorders for whom treatment would be inappropriate including psychotic disorders or active substance abuse. (c). Non-English speakers and people who are unable to read and write English. (d) Should any participants alter their medication during this time period, or begin a course of anti-depressant medication their data will not be included in the final analysis. (e) Inclusion in another treatment trial.